Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Diagnostic accuracy of positron emission tomography tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and meta-analysis.

de Zwart PL, van Dijken BR, Holtman GA, Stormezand GN, Dierckx RA, van Laar PJ, van der Hoorn A.

J Nucl Med. 2019 Sep 20. pii: jnumed.119.233809. doi: 10.2967/jnumed.119.233809. [Epub ahead of print]

PMID:
31541032
2.

Diagnostic and grading accuracy of 18F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis.

Xiao J, Jin Y, Nie J, Chen F, Ma X.

BMC Cancer. 2019 Aug 5;19(1):767. doi: 10.1186/s12885-019-5938-0.

3.

Accuracy of 18F-FDOPA Positron Emission Tomography and 18F-FET Positron Emission Tomography for Differentiating Radiation Necrosis from Brain Tumor Recurrence.

Yu J, Zheng J, Xu W, Weng J, Gao L, Tao L, Liang F, Zhang J.

World Neurosurg. 2018 Jun;114:e1211-e1224. doi: 10.1016/j.wneu.2018.03.179. Epub 2018 Apr 4. Review.

PMID:
29625311
4.

Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.

Tripathi M, Sharma R, D'Souza M, Jaimini A, Panwar P, Varshney R, Datta A, Kumar N, Garg G, Singh D, Grover RK, Mishra AK, Mondal A.

Clin Nucl Med. 2009 Dec;34(12):878-83. doi: 10.1097/RLU.0b013e3181becfe0.

PMID:
20139821
5.

Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis.

Nihashi T, Dahabreh IJ, Terasawa T.

AJNR Am J Neuroradiol. 2013 May;34(5):944-50, S1-11. doi: 10.3174/ajnr.A3324. Epub 2012 Nov 1. Review.

6.

Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.

Bette S, Gempt J, Delbridge C, Kirschke JS, Schlegel J, Foerster S, Huber T, Pyka T, Zimmer C, Meyer B, Ringel F.

World Neurosurg. 2016 May;89:230-9. doi: 10.1016/j.wneu.2016.01.085. Epub 2016 Mar 9.

PMID:
26855307
8.

Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.

Pauleit D, Stoffels G, Bachofner A, Floeth FW, Sabel M, Herzog H, Tellmann L, Jansen P, Reifenberger G, Hamacher K, Coenen HH, Langen KJ.

Nucl Med Biol. 2009 Oct;36(7):779-87. doi: 10.1016/j.nucmedbio.2009.05.005. Epub 2009 Jul 29.

PMID:
19720290
9.

Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.

Dunet V, Pomoni A, Hottinger A, Nicod-Lalonde M, Prior JO.

Neuro Oncol. 2016 Mar;18(3):426-34. doi: 10.1093/neuonc/nov148. Epub 2015 Aug 4. Review.

10.

An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.

Grosu AL, Astner ST, Riedel E, Nieder C, Wiedenmann N, Heinemann F, Schwaiger M, Molls M, Wester HJ, Weber WA.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1049-58. doi: 10.1016/j.ijrobp.2010.07.002. Epub 2011 May 11.

PMID:
21570201
11.

Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis.

van Dijken BRJ, van Laar PJ, Holtman GA, van der Hoorn A.

Eur Radiol. 2017 Oct;27(10):4129-4144. doi: 10.1007/s00330-017-4789-9. Epub 2017 Mar 22. Review.

12.

Diagnostic accuracy of 13N-ammonia PET, 11C-methionine PET and 18F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma.

He Q, Zhang L, Zhang B, Shi X, Yi C, Zhang X.

BMC Cancer. 2019 Apr 8;19(1):332. doi: 10.1186/s12885-019-5560-1.

13.

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC.

Cochrane Database Syst Rev. 2015 Sep 29;(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Review.

14.

Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.

Abrigo JM, Fountain DM, Provenzale JM, Law EK, Kwong JS, Hart MG, Tam WWS.

Cochrane Database Syst Rev. 2018 Jan 22;1:CD011551. doi: 10.1002/14651858.CD011551.pub2. Review.

15.

Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.

Katsanos AH, Alexiou GA, Fotopoulos AD, Jabbour P, Kyritsis AP, Sioka C.

Clin Nucl Med. 2019 Nov;44(11):864-869. doi: 10.1097/RLU.0000000000002654.

PMID:
31205150
16.

A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.

Li Z, Yu Y, Zhang H, Xu G, Chen L.

Nucl Med Commun. 2015 Jul;36(7):695-701. doi: 10.1097/MNM.0000000000000302.

PMID:
25768337
17.

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

Hutterer M, Nowosielski M, Putzer D, Jansen NL, Seiz M, Schocke M, McCoy M, Göbel G, la Fougère C, Virgolini IJ, Trinka E, Jacobs AH, Stockhammer G.

Neuro Oncol. 2013 Mar;15(3):341-51. doi: 10.1093/neuonc/nos300. Epub 2013 Jan 17.

18.

Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses.

Treglia G, Muoio B, Trevisi G, Mattoli MV, Albano D, Bertagna F, Giovanella L.

Int J Mol Sci. 2019 Sep 20;20(19). pii: E4669. doi: 10.3390/ijms20194669. Review.

19.

Imaging modalities for characterising focal pancreatic lesions.

Best LM, Rawji V, Pereira SP, Davidson BR, Gurusamy KS.

Cochrane Database Syst Rev. 2017 Apr 17;4:CD010213. doi: 10.1002/14651858.CD010213.pub2. Review.

20.

Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine (FET).

Langen KJ, Stoffels G, Filss C, Heinzel A, Stegmayr C, Lohmann P, Willuweit A, Neumaier B, Mottaghy FM, Galldiks N.

Methods. 2017 Nov 1;130:124-134. doi: 10.1016/j.ymeth.2017.05.019. Epub 2017 May 24. Review.

PMID:
28552264

Supplemental Content

Support Center